SCHEMBL4788149

SCHEMBL4788149

c1ccc2c(c1)ncn1cccc21

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 1/20 0.42
HTT P42858 2/20 0.41
MAPK1 P28482 1/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
POLB P06746 1/20 0.38
IDO1 P14902 1/20 0.38
TNF P01375 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
FGFR1 P11362 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4792073 0.74 IDO1 (0.53) KDM4ETDP1HTTMAPK1HPGD
SCHEMBL1870141 0.74 MAPT (0.50) KDM4EHTTPOLB
SCHEMBL11582786 0.72 FGFR1 (0.50) KDM4ETDP1HTTHPGDHSD17B10
Water SCHEMBL11581337 0.71 FGFR1 (0.49) KDM4ETDP1HTTHPGDHSD17B10
SCHEMBL29485626 0.71 KDM4E (0.45) KDM4EMAPK1HPGDHSD17B10ALDH1A1
SCHEMBL1370906 0.71 KDM4E (0.45) KDM4EMAPK1HPGDHSD17B10ALDH1A1
SCHEMBL18922383 0.71 KDM4E (0.53) KDM4EHTTMAPK1ALDH1A1POLB
SCHEMBL28182837 0.69 KDM4E (0.44) KDM4EMAPK1HPGDHSD17B10ALDH1A1
SCHEMBL12677712 0.68 USP7 (0.31) SMN1; SMN2
SCHEMBL4513269 0.68 KDM4E (0.46) KDM4ETDP1HTTMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4129653-A CARDIOVASCULAR, ANTIASTHMATIC ORTHO PHARMACEUTICAL CORPORATION (US) 1978-12-12 US claimed
CN-105859727-A Method for preparing 1-substituted pyrrolo[1,5-c]quinazoline framework compounds through copper catalysis 江西师范大学 2016-08-17 CN disclosed
CN-103130810-B Synthesis method of pyrrolo[1,5-c] quinazoline compounds UNIV HENAN NORMAL 2015-02-25 CN disclosed
CN-103130810-B Synthesis method of pyrrolo[1,5-c] quinazoline compounds UNIV HENAN NORMAL 2015-02-25 CN disclosed
CN-103130810-A Synthesis method of pyrrolo[1,5-c] quinazoline compounds UNIV HENAN NORMAL 2013-06-05 CN disclosed
CN-103130810-A Synthesis method of pyrrolo[1,5-c] quinazoline compounds UNIV HENAN NORMAL 2013-06-05 CN disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 WO disclosed
EP-0446141-B1 Imidazo[1,2-c]quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1995-01-18 EP disclosed
US-4129653-A CARDIOVASCULAR, ANTIASTHMATIC ORTHO PHARMACEUTICAL CORPORATION (US) 1978-12-12 US disclosed
US-4129653-A CARDIOVASCULAR, ANTIASTHMATIC ORTHO PHARMACEUTICAL CORPORATION (US) 1978-12-12 US disclosed